Company Monitoring Page for Regeneron

job ratings (see below graph) for Regeneron

latest headlines for company on cafepharma

All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
Sat, 03/21/20 - 10:59 pm
Tags:
COVID-19, Gilead Sciences, Mylan, Bayer, chloroquine, hydroxychloroquine, Fujifilm, Avigan, Kevzara, Actemra, Regeneron, Sanofi, Roche
Inside Regeneron's R&D war room, sleepless nights and 'esprit de corps' in hunt for COVID-19 therapy
Fierce Pharma
Sat, 03/21/20 - 12:09 am
Tags:
Regeneron, R&D, COVID-19, Kevzara
Regeneron Could Start Testing a Coronavirus Cocktail Therapy by Early Summer
Motley Fool
Tue, 03/17/20 - 12:08 pm
Tags:
Regeneron, COVID-19, coronaviruses, clinical trials
Regeneron, Sanofi to iniate human trials of treatment for patients with severe COVID-19
Yahoo/Marketwatch
Mon, 03/16/20 - 10:48 am
Tags:
Regeneron, Sanofi, clinical trials, Kevzara, COVID-19, coronaviruses
Could arthritis med Kevzara hold promise against the novel coronavirus? Sanofi, Regeneron aim to find out
Fierce Pharma
Wed, 03/11/20 - 10:35 am
Tags:
Kevzara, Regeneron, Sanofi, COVID-19, coronaviruses
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Sun, 03/8/20 - 11:26 pm
Tags:
Gilead Sciences, GSK, Innovio, JNJ, Moderna Therapeutics, Regeneron, Sanofi, Takeda, Vir Biotchnology
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Fierce Pharma
Sat, 02/29/20 - 07:13 pm
Tags:
Vertex Pharmaceuticals, Alexion, Regeneron, GSK, earnings
Novartis knocked by safety scare
EP Vantage
Tue, 02/25/20 - 04:55 pm
Tags:
Novartis, Regeneron, Beovu, Eylea, wet age-related macular degeneration
Regeneron’s Eylea delivers positive two-year results in PANORAMA trial
Pharmaceutical Business Review
Mon, 02/10/20 - 10:13 am
Tags:
Regeneron, Eylea, diabetic neuropathy, NPDR, clinical trials
Top Companies in Pharm Country Ranked by Revenue
BioSpace
Fri, 02/7/20 - 11:46 pm
Tags:
Connecticut, New York, New Jersey, Pennsylvania, Rhode Island, Merck, Bristol-Myers Squibb, Regeneron, Ipsen, Ovid Therapeutics, Codagenix
Are Novartis and Regeneron seeing the same thing?
BioPharma Dive
Fri, 02/7/20 - 11:42 pm
Tags:
Novartis, Regeneron, physicians, Eylea, Beovu
Sanofi C-suite explains Regeneron deal 'simplification,' ramping up its pipeline
Fierce Biotech
Fri, 02/7/20 - 10:19 am
Tags:
Sanofi, M&A, Regeneron, Synthorx
Regeneron (REGN) Q4 Earnings and Revenues Surpass Estimates
Yahoo/Zacks.com
Thu, 02/6/20 - 11:00 am
Tags:
Regeneron, earnings
Drugmaker Regeneron working with U.S. HHS to develop coronavirus treatment
Reuters
Tue, 02/4/20 - 10:17 am
Tags:
Regeneron, Wuhan Coronavirus, HHS, China
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
Tags:
innovation, Regeneron, Verily, Illumina, Biogen, Bayer, Bluebird Bio, Novartis, GSK, Genentech, Amgen
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
Tags:
JPMHC 2020, Bristol-Myers Squibb, Vertex Pharmaceuticals, Biomarin, Regeneron, Biogen, Alexion, Gilead Sciences, Amgen
Regeneron's bone disease drug delivers in phase 2, poised for FDA filing
Fierce Biotech
Thu, 01/9/20 - 10:55 am
Tags:
Regeneron, Rare Diseases, FDA, clinical trials, garetosmab
Regeneron to lay off field staffers as it restructures Sanofi partnership
Fierce Pharma
Thu, 01/2/20 - 11:03 am
Tags:
Regeneron, Sanofi, layoffs
Sanofi, Regeneron to Amend Agreement for Kevzara & Praulent
Yahoo/Zacks.com
Wed, 12/11/19 - 09:56 pm
Tags:
Sanofi, Regeneron, Kevzara, Praulent
Leo's Dupixent rival hits all endpoints in pivotal program
Fierce Biotech
Wed, 12/11/19 - 10:36 am
Tags:
LEO Pharma, atopic dermatitis, tralokinumab, Sanofi, Regeneron, Dupixent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.